Previous studies have indicated that NT-proBNP may be useful in the identification of non-high and high-risk patients and low plasma NT-proBNP levels predicts an uncomplicated clinical hospital course in APE patients [6,8]. Here, NPPB is linked to apparent mineralocorticoid excess.